Yabao Pharmaceutical Group Co., Ltd (600351.SS) SHH
6.50
-0.23(-3.42%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.4B |
| Enterprise Value | 3.92B |
| P/E Ratio | 20.41 |
| PEG Ratio | -3.37 |
| Price/Sales Ratio | 1.98 |
| Price/Book Ratio | 1.63 |
| Enterprise/Revenue | 1.74 |
| Enterprise/EBITDA | 9.92 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.12 |
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 2.69B |
| Revenue/Share | 3.25 |
| Gross Profit | 1.36B |
| EBITDA | 433.77M |
| Net Income | 242.69M |
| Diluted EPS | 0.34 |
Balance Sheet
| Total Cash | 654.37M |
| Total Cash/Share | 0.93 |
| Total Debt | 101.4M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 3.14 |
| Book Value Per Share | 3.94 |
Price History
| 52-Week Change | 3.17 |
| 52-Week High | 8.68 |
| 52-Week Low | 5.35 |
| Moving Average 50 Days | 6.65 |
| Moving Average 200 Days | 6.76 |
Statistics
| Average Volume | 12.48M |
| Shares Outstanding | 692M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 7.69 |
| Payout Ratio | 0.94 |
| Last Split Factor | 2:1 |
| Last Split Date | May 28, 2010 |
